Seno-Therapeutics Summit 2025 

Draft Program

08:30–09:15 — Registration

09:15–09:25 — Welcome Note

Session 1

New Discoveries, Biomarkers and Clinical Trials: A perspective from academics

09:25–09:50 — James Kirkland (UCLA)
09:50–10:15 — Marissa Schafer (Mayo Clinic)
10:15–10:40 — Andrea Alimonti (IOR and ETH)

10:40–11:10 — Coffee break

11:10–11:35 — Mike Sapieha (Unity Biotechnogies)
11:35–12:00 — Daohong Zhou (UT San Antonio)
12:00–12:25 — Frederick Beddingfield (Rubedo Life Sciences)

 Round Table 1

Biomarkers and Clinical Trial Designs for Senotherapeutics

12:25–12:50

Frederick Beddingfield (Rubedo Life Sciences)
James Kirkland (UCLA)
Marissa Schafer (Mayo Clinic)

12:50–13:50 — Lunch break

 Round Table 2

Cellular Senescence & Longevity Therapeutics: Are Big Pharma Ready to Bet on Aging Biology as key driver and mechanism of chronic diseases?

13:50–14:20

Benjamin Yaden (Eli Lilly)
TBD  — Chiesi Pharmaceutical

TBD — Novartis

Session 2

Early stage companies

14:20–14:45 — Jia Xi (OneSkin)
14:45–15:10 — John Lewis (Oisin)
15:10–15:35 — Robin Mansukhani (Decidous Therapeutics)

15:35–16:00 — Coffee break

16:00–16:25 — EOS Senolytix
16:25–16:50 — Phoenix Senolytix

Round Table 3

From Gene Delivery to Decentralized Discovery – Translating Senescence Science into the Next Generation of Senotherapeutics

Paolo Binetti (VitaDAO)
Mac Davis (Minicircle)
TBD — Healthspan Ventures

17:20–17:45 — Conclusions and final remarks